Get short, timely messages from ISR Reports.

Twitter is a rich source of instantly updated information. It's easy to stay updated on an incredibly wide variety of topics. Join today and follow @ISRreports.

Get updates via SMS by texting follow ISRreports to 40404 in the United States
Codes for other countries

Two-way (sending and receiving) short codes:
Country Code For customers of
Australia
  • 0198089488 Telstra
Canada
  • 21212 (any)
United Kingdom
  • 86444 Vodafone, Orange, 3, O2
Indonesia
  • 89887 AXIS, 3, Telkomsel
Ireland
  • 51210 O2
India
  • 53000 Bharti Airtel, Videocon
Jordan
  • 90903 Zain
New Zealand
  • 8987 Vodafone, Telecom NZ
United States
  • 40404 (any)

ISRreports

  1. ISR Report: The State of Investigator Recruitment in #ClinicalTrials - Novel insight from 116 #pharma decision-makers bit.ly/JVKsq6
  2. #Pharma #Clinicaltrials #Patient recruitment RT @Pharmalot: CROs Can’t Recruit Patients Fast Enough: Survey bit.ly/L2tybx
  3. #Pharma report on "The State of Patient Recruitment in #clinicaltrials". Download free preview of sample pages/full TOC bit.ly/ImE2vQ
  4. ISR released "The State of Patient Recruitment in #clinicaltrials". Download a free preview for sample pages / full TOC bit.ly/ImE2vQ
  5. Only 13% of US Payers use the term “head-to-head” when defining Comparative Effectiveness Research. isrreports.com/industry-repor…
  6. ISR just registered a team for this year's Joey O Charity Bocce Classic benefiting Cystic Fibrosis in Raleigh on 4/29 bit.ly/HTJPZB
  7. The age old question... eDetailing or In-person Detailing??? #pharma bit.ly/yfyaaI
  8. Post-marketing Safety Report: Market dynamics / outsourcing of PhIV nonintervential, REMS, Signal Mgmt. studies bit.ly/HntKxg #pharma
  9. eDetailing: 3 of 4 specialties we surveyed (A&I, Cardiology, Family Med., and Oncology) desire more eDetails per week bit.ly/yrrrrZ
  10. Post-marketing Market Dynamics: Sponsor's prefer specialty safety providers over large and mid size providers for REMS bit.ly/HntKxg
  11. From "The State of the Phase I Market" - 83% of sponsors say they no longer possess ANY internal Phase I capacity bit.ly/HNIl77
  12. 52% of respondents say feasibility analysis could be improved. How are they under performing and what is to fix? bit.ly/AqUSnz
  13. On behalf of the ISR Health Panel, we've just donated a combined $4,300 to @MakeAWish and @MSF_USA. bit.ly/AF5sPL
  14. 17% of oncologists indicated eDetail info including comparative data for competitive products is most important isrreports.com/industry-repor…
  15. 7 of 14 CROs meet or exceed sponsor’s expectations for Meeting Overall Project Timelines: isrreports.com/industry-repor…
  16. Comparative Effectiveness Research – formulary placement and US Payers. ACT webinar: appliedclinicaltrialsonline.com/CER. Good report: isrreports.com/industry-repor…
  17. ISR is at #PCTUS and giving away a FREE REPORT everyday of the conference. Stop by booth #927 to enter the raffle bit.ly/oLyxTO
  18. ISR will be launching our 4th annual CRO Quality Benchmarking report today. Visit ISRreports.com to download the report preview.